The Netherlands declines to reimburse exenatide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
The archive
Page 76 of 170 of this archive, newest first.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
A supplier suspends shipping to Argentina after 14 consecutive customs detentions
The route did not close because of a rule about peptides.
What a 7% rise in coupling-reagent prices does to a 10 mg vial
Follow the resin, not the catalogue.
The shortage years, and what they taught about interruption
Real-world persistence figures, with their definitions stated, because the definitions are doing most of the work.
The column is a choice, and it is not a small one
We set out the parameters a method disclosure would contain, all of which are known to whoever ran the sample and none of which is commercially sensitive.
The quiet end of Calder Vale Peptides of Skipton
A proper account of an operation that existed, and of what closing it cost.
Medutest result on a Qingdao survodutide lot lands 2.7 points below the supplier’s figure
The Journal submitted the sample and paid for the analysis. The vendor was told in advance.
What changed at SGN in May, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
FLOW misses on a secondary endpoint the coverage has not mentioned
A design note rather than a result: what the comparator was, and what that permits you to conclude.
The label says four weeks. The clinic says whatever holds.
Deviation from the printed ladder is not non-compliance. In this class it is the modal behaviour of competent prescribing.
The interventions with trial support, and the much longer list without
The intervention with the clearest evidence is the one nobody frames as an intervention: adjusting the dose.
The sample is not the batch
A result on one vial generalises to a batch only if the vial was drawn in a way that makes it representative — and nobody records how it was drawn.
Sweden declines to reimburse liraglutide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
Wuhan export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.
Switzerland pharmacy body issues counselling standards for semaglutide initiation
The evidence base is thin and the document says so, which is to its credit.
Diminishing returns, quantified
Where the curve flattens, what flattens with it, and what does not.
The United Kingdom caps liraglutide prescribing to 18 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
SURPASS-4 extension data: what happens after the trial stops
A design note rather than a result: what the comparator was, and what that permits you to conclude.
The 10-day notice: how a compounding wind-down works in Argentina
The document is four pages. Three of them are about dates.
Inspectors cite Halvard & Pike Apothecary of Portland, Maine over sterility assurance
The observation that closes a facility is rarely the dramatic one.
The withdrawal trials, read as designs rather than warnings
The evidence on stopping is better than the evidence on almost anything else in this field, because somebody deliberately randomised it.
The instrument was calibrated on Tuesday. Your sample ran on Friday.
Parts per million sound impressive until they are converted into daltons at the molecular weight of the thing being measured.
What changed at MKM in May, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
VendorInvestigate result on a Xianning cagrilintide lot lands 2.6 points below the supplier’s figure
The result is unremarkable. What the report omits is not.
The consolidator trading as Meridian Freight Partners enters a consent decree and stops sterile preparation
The observation that closes a facility is rarely the dramatic one.
A supplier suspends shipping to Canada after 19 consecutive customs detentions
The route did not close because of a rule about peptides.
The impurity hiding underneath the parent peak
Where two methods disagree, the conservative convention is to report the lower figure. It is not universal, and whether a laboratory follows it belongs on the report.
Delayed emptying explains some of this, and not all of it
The receptor populations that produce satiety and the ones that produce nausea overlap substantially. That is why the ceiling of this drug class is where it is, and it is…
Independent analysis puts a Homopeptide retatrutide lot at 98.9%, against 98.1% on the certificate
The Journal submitted the sample and paid for the analysis. The vendor was told in advance.